Literature DB >> 33389450

Association of physician experience with a higher prescription rate of anti-influenza agents in low-risk patients.

Koji Nakajima1, Hiroyuki Akebo1, Yukio Tsugihashi2, Hiroyasu Ishimaru1, Ryuichi Sada3.   

Abstract

During the influenza season, most patients suspected of having influenza undergo rapid influenza diagnostic tests (RIDTs) in Japan despite their low sensitivity. However, the physician's actual rationale for prescribing antivirals, besides the results of RIDTs, remains poorly understood. Our study sought to identify the role of clinical information and physicians' experience in the initiation of anti-influenza agents. We retrospectively reviewed 380 patients who underwent RIDTs at the emergency department of our hospital from September 2018 to May 2019. Data regarding sex, age, etc., which could affect the decision of prescribing antivirals, were extracted from medical records. We performed logistic regression analysis to analyze the concurrent effect of potentially relevant clinical factors, results of RIDTs, and the physician's status on antiviral prescription. Multivariable analysis revealed that a positive RIDT had the largest effect on antiviral prescription, followed by physician status, high regional influenza activity, and patients' presentation within 12 h of symptom onset. Patient's age, comorbidities, and presentation after 48 h of symptom onset were not associated with antiviral treatment. Physicians with more years of experience were significantly more likely to prescribe antivirals for patients with low risk of complications. Our findings revealed the physicians' rationale for initiating antiviral treatment and the discrepancy with guideline indications of antivirals, which is the patient's age and comorbidities. Physicians, especially those with more than 3 years of experience, frequently prescribed antivirals for patients with low risk of complications; thus, educational interventions against this population could be useful to improve this situation.
© 2021. Società Italiana di Medicina Interna (SIMI).

Entities:  

Keywords:  Antiviral agents; Influenza; Influenza testing; Medical records; Prescriptions; Rapid influenza diagnostic testing

Year:  2021        PMID: 33389450     DOI: 10.1007/s11739-020-02570-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  20 in total

Review 1.  Accuracy of rapid influenza diagnostic tests: a meta-analysis.

Authors:  Caroline Chartrand; Mariska M G Leeflang; Jessica Minion; Timothy Brewer; Madhukar Pai
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

2.  Impact of rapid diagnosis on management of adults hospitalized with influenza.

Authors:  Ann R Falsey; Yoshihiko Murata; Edward E Walsh
Journal:  Arch Intern Med       Date:  2007-01-22

Review 3.  Widespread use of neuraminidase inhibitors in Japan.

Authors:  Norio Sugaya
Journal:  J Infect Chemother       Date:  2011-08-18       Impact factor: 2.211

4.  Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza.

Authors:  Laurent Busson; Bhavna Mahadeb; Marc De Foor; Olivier Vandenberg; Marie Hallin
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-27       Impact factor: 2.803

5.  [Comparison of detection sensitivity in rapid-diagnosis influenza virus kits].

Authors:  Osamu Tokuno; Miki Fujiwara; Yoshimi Nakajoh; Sumika Yamanouchi; Masayo Adachi; Akiko Ikeda; Shigeo Kitayama; Toshio Takahashi; Tetsuo Kase; Shouhiro Kinoshita; Shunichi Kumagai
Journal:  Kansenshogaku Zasshi       Date:  2009-09

6.  A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department.

Authors:  Anne J Blaschke; Daniel J Shapiro; Andrew T Pavia; Carrie L Byington; Krow Ampofo; Chris Stockmann; Adam L Hersh
Journal:  J Pediatric Infect Dis Soc       Date:  2013-11-13       Impact factor: 3.164

7.  Detection sensitivity of influenza rapid diagnostic tests.

Authors:  Yuko Sakai-Tagawa; Makoto Ozawa; Shinya Yamada; Yuko Uchida; Takehiko Saito; Kazuo Takahashi; Norio Sugaya; Masato Tashiro; Yoshihiro Kawaoka
Journal:  Microbiol Immunol       Date:  2014-10       Impact factor: 1.955

8.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 20.999

Review 9.  Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Authors:  Tom Jefferson; Mark Jones; Peter Doshi; Elizabeth A Spencer; Igho Onakpoya; Carl J Heneghan
Journal:  BMJ       Date:  2014-04-09

Review 10.  Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis.

Authors:  Joanna Merckx; Rehab Wali; Ian Schiller; Chelsea Caya; Genevieve C Gore; Caroline Chartrand; Nandini Dendukuri; Jesse Papenburg
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.